Phase I dose escalation study of the safety, tolerability, pharmacokinetics and antiviral activity of Omega DUROS [an implantable drug delivery system containing omega interferon] and ribavirin in subjects with chronic hepatitis C previously treated with pegylated interferon and ribavirin
Phase of Trial: Phase I
Latest Information Update: 07 Jun 2011
At a glance
- Drugs Interferon omega; Ribavirin
- Indications Hepatitis C
- Focus Adverse reactions; Therapeutic Use
- 07 Jun 2011 Actual end date (Mar 2010) added as reported by ClinicalTrials.gov.
- 07 Jun 2011 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
- 12 Jan 2009 Status changed from recruiting to active, no longer recruiting as reported by ClinicalTrials.gov.